Report #2897134

Received May 19, 2026

Office visit

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 53 yrs
State: PA
Recovered: Not recovered
Vaccinated: Apr 28, 2026
Onset: May 5, 2026
Days to onset: 7
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	nt357	IM / LA

Symptoms (3)

Injection site erythemaInjection site rashInjection site swelling

Symptom narrative

Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: pt stated she is a physician and noticed redness/swelling/rash at injection site approx 7 days after administration, tried benadryl, and called her physician friend who is a dermatologist to obtain a topical cream. pt states other than the injection site, overall she feels fine. pharmacist asked pt to call pharmacy is further symptoms/side effects develope or worsen , Other Vaccines: VaccineTypeBrand: shingrix; Manufacturer: glaxosmith; LotNumber: nt357; Route: im; BodySite: left deltoid; Dose: 00; VaxDate: 04/28/2026

Allergies

miconazole nitrate, tramadol